# FDA 483 - Sichuan Qingmu Pharmaceutical Co., Ltd - October 24, 2025

Source: https://www.globalkeysolutions.net/records/483/sichuan-qingmu-pharmaceutical-co-ltd/56086bde-0559-4711-9668-3b5af53c6726

> FDA 483 for Sichuan Qingmu Pharmaceutical Co., Ltd on October 24, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sichuan Qingmu Pharmaceutical Co., Ltd
- Inspection Date: 2025-10-24
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Sichuan Qingmu Pharmaceutical Co. Ltd., an API manufacturer in Meishan City, China, from October 20-24, 2025, identified one observation. The firm was cited for not maintaining adequate records associated with the receiving of raw materials, specifically lacking a chronological and sequential receiving log. This indicates a deficiency in their paper-based material management system.

## Related Documents

- [483 - 2021-09-07](https://www.globalkeysolutions.net/records/483/sichuan-qingmu-pharmaceutical-co-ltd/ad07a28c-e35c-4fa4-ab3b-8609bf1e66c5)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)
- [issuing_officer](https://www.globalkeysolutions.net/people/truong-xuan-nguyen/4ccdfd9f-f002-4498-829e-6e951e9d5e43)

Company: https://www.globalkeysolutions.net/companies/sichuan-qingmu-pharmaceutical-co-ltd/821a1489-2969-47a3-8321-b97728ac795a

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8